Incannex Healthcare IXHL
NASDAQ IXHL
$3.57 -0.05 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Cash from Investing Activities (2023 - 2026)

Incannex Healthcare (IXHL) posted Cash from Investing Activities of -$18000.0 for Q1 2026, down 350.0% sequentially from -$4000.0 in Q4 2025.

Incannex Healthcare (IXHL) Cash from Investing Activities (2023 - 2026) Analysis & Trends

Incannex Healthcare has reported Cash from Investing Activities for 4 years, with the latest figure at -$18000.0 in Q1 2026.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64000.0 (down 14.29% YoY) and the FY2025 annual result came in at -$8000.0, up 97.11% from the prior year.
  • Cash from Investing Activities declined to -$18000.0 in Q1 2026 per IXHL's latest filing, from -$4000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $6000.0 in Q1 2024 and troughed at -$221000.0 in Q3 2023.
  • A 4-year average of -$60444.4 and a median of -$32000.0 in 2023 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 118.75% in 2024, down 98.25% in 2024.
  • Over 4 years, Cash from Investing Activities stood at -$59000.0 in 2023, then soared by 94.92% to -$3000.0 in 2024, then plunged by 33.33% to -$4000.0 in 2025, then plunged by 350.0% to -$18000.0 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$18000.0, -$4000.0, and -$42000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Incannex Healthcare 44.39 Mn 44.39 Mn - -18,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,000.00
Mar 31, 2026 -18,000.00
Dec 31, 2025 -4,000.00
Dec 31, 2025 -4,000.00
Sep 30, 2025 -42,000.00
Sep 30, 2025 -42,000.00
Jun 30, 2024 -3,000.00
Jun 30, 2024 -3,000.00
Mar 31, 2024 6,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 -59,000.00
Dec 31, 2023 -59,000.00
Sep 30, 2023 -221,000.00
Sep 30, 2023 -221,000.00
Jun 30, 2023 -171,000.00
Jun 30, 2023 -171,000.00
Mar 31, 2023 -32,000.00
Mar 31, 2023 -32,000.00